Literature DB >> 17349419

Risedronate-induced Hepatitis.

Michael B Phillips.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17349419     DOI: 10.1016/j.amjmed.2006.04.032

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  6 in total

1.  Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.

Authors:  S A Polyzos; J Kountouras; A D Anastasilakis; I Litsas; M Kita; G Arsos; E Moralidis; E Terpos
Journal:  Osteoporos Int       Date:  2010-04-21       Impact factor: 4.507

Review 2.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

3.  Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis.

Authors:  Brian J Gates; Shyamal Das
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-01-05

4.  Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Authors:  J-J Body; P Bergmann; S Boonen; J-P Devogelaer; E Gielen; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-02-04       Impact factor: 4.507

5.  Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis.

Authors:  Yan Jiang; Yong Fu; Xiao-ping Xing; Mei Li; Ou Wang; Wei-bo Xia; Xun-wu Meng
Journal:  Eur J Med Res       Date:  2015-08-22       Impact factor: 2.175

6.  Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis.

Authors:  Yanhui Lu; Yu Pei; Yinghong Shao; Shuangtong Yan; Lichao Ma; Fusheng Fang; Mengmeng Jin; Minyan Liu; Jian Li; Chunlin Li
Journal:  EXCLI J       Date:  2013-02-13       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.